Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Astha Kumar
Observed name:
A. Kumar
Institution:
Datta Meghe Institute of Higher Education and Research
Observed institutions:
Cellworks Research (India),
Datta Meghe Institute of Higher Education and Research,
National Institute of Solar Energy
ORCID:
0009-0003-3662-2135
Observed ORCID:
0009-0003-3662-2135
OpenAlex ID:
A5063963115
Artificial intelligence in health care: A review of uses, challenges and potential uses
2024
·
Jagadish Makade
, Nandkishor Bankar
, et al.
·
AIP conference proceedings
·
13
Recent Outbreak of Monkeypox: Implications for Public Health Recommendations and Crisis Management in India
2023
·
Astha Kumar
, Sonali K Borkar
, et al.
·
Cureus
·
3
PDF
Application of artificial intelligence as a public health tool: Current scenario and challenges
2024
·
Astha Kumar
, Nandkishor Bankar
, et al.
·
AIP conference proceedings
·
2
P12.06 Computational Omics Biology Model (CBM) Identifies PD-L1 Immunotherapy Response Criteria Based on Genomic Signature of NSCLC
2021
·
M. Castro
, A.K. Ganti
, et al.
·
Journal of Thoracic Oncology
·
1
A randomized, double-blind, phase III study in India to evaluate efficacy, safety, pharmacokinetics (PK), and immunogenicity of ZRC-3277 (pertuzumab biosimilar) in comparison with Perjeta® (pertuzumab) in patients with HER2-positive metastatic breast cancer
2024
·
R. Kothari
, M. Doshi
, et al.
·
European Journal of Cancer
PDF
eHealth and telehealth adoption in rural and underserved communities in India: A review
2024
·
Pratik S. Awale
, Astha Kumar
, et al.
·
AIP conference proceedings
Fever Rash (FR) Surveillance System Assessment for Detection of Measles-Rubella Disease at Raipur District, Chhattisgarh State, India, April 2022 – August 2022
2023
·
Nitin Patil
, Maithilee Patil
, et al.
·
SBV Journal of Basic Clinical and Applied Health Science
PDF
P70.03 Computational Omics Biology Model (CBM) Identifies Amplifications of Chromosome 6p to Predict Chemotherapy Resistance
2021
·
V. Velcheti
, A.K. Ganti
, et al.
·
Journal of Thoracic Oncology
PDF
Pcn454 a Matching-adjusted Indirect Comparison (maic) of Elotuzumab/pomalidomide/dexamethasone (epd) Versus Panobinostat/bortezomib/dexamethasone (pano-vd) and Daratumumab Monotherapy for Relapsed/refractory Multiple Myeloma (rrmm)
2019
·
R. Potluri
, C. Chen
, et al.
·
Value in Health
PDF
P1.15-02 Role of mTOR Inhibitor Everolimus in the Treatment of Metastatic Thymic Epithelial Tumors
2019
·
J. Hellyer
, S. Padda
, et al.
·
Journal of Thoracic Oncology
Pcn254 an Indirect Comparison of Elotuzumab, Carfilzomib, and Daratumumab When Given in Combination With Pomalidomide and Dexamethasone for Relapsed/refractory Multiple Myeloma
2019
·
R. Potluri
, C. Chen
, et al.
·
Value in Health
P1.14-17 Identification of Molecular Subtypes of Thymic Epithelial Tumors and Novel Treatments Using a Computational Biological Model
2018
·
S. Padda
, Y. Gokmen-Polar
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
12
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type
